SCHEMBL24263381

SCHEMBL24263381

COc1ccc(CN(C)c2cc(Cl)nn3c(C(N)=O)cnc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PDE1B Q01064 8/20 0.39
▸ PARP1 P09874 3/20 0.39
▸ PARP2 Q9UGN5 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ ACLY P53396 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NR3C1 P04150 1/20 0.35
▸ ZAP70 P43403 1/20 0.35
▸ KARS1 Q15046 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16794676 0.91 PDE1B (0.40) PDE1BALDH1A1HTTSMN1; SMN2HSP90AA1
SCHEMBL18161034 0.91 PDE1B (0.41) PDE1BALDH1A1HTTSMN1; SMN2HSP90AA1
SCHEMBL16812352 0.88 PDE1B (0.38) PDE1BALDH1A1HTTSMN1; SMN2HSP90AA1
SCHEMBL16794693 0.87 MAPT (0.42) PDE1BALDH1A1HTTSMN1; SMN2MEN1
SCHEMBL16812355 0.87 ALDH1A1 (0.39) PDE1BALDH1A1HTTSMN1; SMN2MEN1
SCHEMBL16812493 0.87 NR3C1 (0.39) PDE1BALDH1A1HTTSMN1; SMN2MEN1
SCHEMBL3021969 0.86 BCL2A1 (0.39) PDE1BALDH1A1HTTSMN1; SMN2MEN1
SCHEMBL20504495 0.86 PDE1B (0.38) PDE1BPARP1PARP2MEN1KMT2A
SCHEMBL29754326 0.84 PTPN1 (0.38) PDE1BALDH1A1HTTSMN1; SMN2HSP90AA1
SCHEMBL16812354 0.84 CDK5 (0.39) PDE1BSMN1; SMN2MEN1KMT2ANR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022037694-A1 A CLASS OF FIVE- AND SIX-MEMBERED HETEROCYCLIC COMPOUNDS AND USE THEREOF AS PROTEIN RECEPTOR KINASE INHIBITORS 轶诺(浙江)药业有限公司 2022-02-24 — — WO disclosed
Send feedback